TLSA
TLSA
NASDAQ · Biotechnology

Tiziana Life Sciences Ltd

$1.50
-0.06 (-3.85%)
As of May 16, 2:08 AM ET ·
Financial Highlights (FY 2025)
Revenue
60.16M
Net Income
-7,561,680
Gross Margin
43.5%
Profit Margin
-12.6%
Rev Growth
-4.1%
D/E Ratio
1.23
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 43.5% 43.5% 43.5%
Operating Margin -12.4% -12.4% -14.2%
Profit Margin -12.6% -12.7% -14.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 60.16M 53.18M 50.95M
Gross Profit 26.14M 23.11M 22.14M
Operating Income -7,468,587 -6,590,382 -7,256,071
Net Income -7,561,680 -6,775,030 -7,233,045
Gross Margin 43.5% 43.5% 43.5%
Operating Margin -12.4% -12.4% -14.2%
Profit Margin -12.6% -12.7% -14.2%
Rev Growth -4.1% +12.5% -5.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 71.73M 85.83M 81.65M
Total Equity 58.15M 60.02M 66.17M
D/E Ratio 1.23 1.43 1.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -8,587,792 -7,436,735 -8,070,839
Free Cash Flow -10,429,515 -10,842,286 -7,296,543